dc.creator | Jara Moreno, Daniela | |
dc.creator | Riveros Salvatierra, Ana L. | |
dc.creator | Barriga G., Andrés | |
dc.creator | Kogan, Marcelo J. | |
dc.creator | Delporte Vergara, Carla | |
dc.date.accessioned | 2020-06-15T23:20:37Z | |
dc.date.available | 2020-06-15T23:20:37Z | |
dc.date.created | 2020-06-15T23:20:37Z | |
dc.date.issued | 2020 | |
dc.identifier | Curr Pharm Des 2020;26(12):1365-1376 | |
dc.identifier | 10.2174/1381612826666200113160840 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/175503 | |
dc.description.abstract | The beta-amyloid peptide (1-42) is a molecule capable of aggregating into neurotoxic structures that have been implicated as potential etiological factors of Alzheimer's Disease. The aim of this study was to evaluate the inhibition of beta-amyloid aggregation of ethyl acetate and ethanolic extracts obtained from Ugni molinae leaves on neurotoxic actions of beta-amyloid aggregates. Chemical analyses were carried out with the extracts in order to determine their phenolic profile and its quantification. Both extracts showed a tendency to reduce neuronal deaths caused by beta-amyloid. This tendency was inversely proportional to the evaluated concentrations. Moreover, the effect of EAE and ETE on beta-amyloid aggregation was studied by fluorimetric T Thioflavin assay and transmission electronic microscopy (TEM); the extracts showed a modulation in the aggregation process. Partly, it is believed that these effects can be attributed to the polyphenolic compounds present in the extracts. | |
dc.language | en | |
dc.publisher | Bentham Science Publishers | |
dc.source | Current Pharmaceutical Design | |
dc.subject | Ugni molinae | |
dc.subject | Beta-amyloid aggregation | |
dc.subject | T Thioflavin | |
dc.subject | Polyphenols | |
dc.subject | Beta-amyloid disaggregation | |
dc.subject | Fluorimetric | |
dc.title | Inhibition of beta-amyloid Aggregation of Ugni molinae Extracts | |
dc.type | Artículo de revista | |